Finance

Beta
Lists
CGEM:NASDAQ
Cullinan Therapeutics Inc
17,69 $
+7,80%
(+1,28) 1D
17,69 $
0,00% (0,00)
After hours
Closed: 17 шіл., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CGEM...
Open
16,06 $
High
17,88 $
Low
16,00 $
Mkt. cap
1,09 млрд
Avg. vol.
1,21 млн
Volume
594,76 м.
52-wk high
19,43 $
52-wk low
5,68 $
EPS
-3,72 $
Beta
-0,02
Shares outstanding
61,46 млн
No. of employees
109
Open
16,06 $
High
17,88 $
Low
16,00 $
Mkt. cap
1,09 млрд
Avg. vol.
1,21 млн
Volume
594,76 м.
52-wk high
19,43 $
52-wk low
5,68 $
EPS
-3,72 $
Beta
-0,02
Shares outstanding
61,46 млн
No. of employees
109
News stories
From sources across the web
Stock Traders Daily
Stock Traders Daily
·
1 күн бұрын
Why (CGEM) Price Action Is Critical for Tactical Trading
About Cullinan Therapeutics Inc
CEO-
Employees109
Founded2016
Headquarters-
Sector-
Analyst ratings
Based on 11 analysts giving stock ratings to CGEM in the past 3 months
Strong buy
Buy
11
Hold
0
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for CGEM in the last 3 months.
Highest
Current 17,69 $
46,00 $ (+160,03%)
Average
33,56 $ (+89,71%)
Lowest
24,00 $ (+35,67%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert Burns
H.C. Wainwright
Buy
Reiterated
30,00 $
+69,6%
06/24/2026
Robert Driscoll
Wedbush
Buy
Maintained
37,00 $
+109,2%
06/11/2026
Julian Harrison
BTIG
Buy
Reiterated
38,00 $
+114,8%
06/10/2026
Marc Frahm
TD Cowen
Buy
Maintained
-
-
06/10/2026
Kaveri Pohlman
Clear Street
Buy
Maintained
46,00 $
+160%
06/10/2026
Boris Peaker
JonesTrading
Buy
Maintained
36,00 $
+103,5%
06/10/2026
Samantha Semenkow
Citi
Buy
Reiterated
33,00 $
+86,5%
06/10/2026
Alex Thompson CFA
Stifel Nicolaus
Buy
Maintained
28,00 $
+58,3%
06/08/2026
Sean Laaman
Morgan Stanley
Buy
Maintained
30,00 $
+69,6%
06/07/2026
Matt Phipps
William Blair
Buy
Reiterated
-
-
06/08/2026
David Dai
UBS
Buy
Initiated
24,00 $
+35,7%
06/08/2026
Soumit Roy
JonesTrading
Buy
Maintained
36,00 $
+103,5%
04/06/2026
Bradley Canino
Guggenheim
Buy
Reiterated
30,00 $
+69,6%
03/10/2026
Last report
2026 ж. 07 мам.
Fiscal period
Q1 2026
EPS / Est. (USD)
-0,75 $ / -0,84 $
+11,06%beat
Revenue / Est. (USD)
- / 0,00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 ж. мау.
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
61,03 млн
41,97 млн
42,94 млн
42,12 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14,77 млн
13,63 млн
12,31 млн
11,57 млн
Operating expense
75,80 млн
55,60 млн
55,26 млн
53,70 млн
Total operating expenses
75,80 млн
55,60 млн
55,26 млн
53,70 млн
Operating income
-75,80 млн
-55,60 млн
-55,26 млн
-53,70 млн
Other non operating income
-181,00 м.
-108,00 м.
-69,00 мың
-62,00 мың
EBT including unusual items
-70,06 млн
-50,61 млн
-50,71 млн
-49,66 млн
EBT excluding unusual items
-70,06 млн
-50,61 млн
-50,71 млн
-49,66 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-70,06 млн
-50,61 млн
-50,71 млн
-49,66 млн
Net profit margin
-
-
-
-
Earnings per share
-1,07
-0,77
-0,77
-0,75
Interest and investment income
5,92 млн
5,09 млн
4,62 млн
4,10 млн
Interest expense
-
-
-
-
Net interest expenses
5,92 млн
5,09 млн
4,62 млн
4,10 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-75,72 млн
-55,52 млн
-55,18 млн
-53,62 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more